Stefanie Simons Camassi
Nurse Practitioner · Orem, UTNPI 1902535107
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,355 of the $5,164 with a category attached, or 65.0%. 35 manufacturers reported payments, led by Novartis at 43.8% of the total. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Genmab U.S., Inc.$230
- Daiichi Sankyo Inc.$211
- Merck$201
- EMD Serono, Inc.$176
- Regeneron Healthcare Solutions, Inc.$174
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,35565%
- Education$1964%
- Other$1,61331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 68 | $2,261 |
| Genmab U.S., Inc. | 17 | $230 |
| Daiichi Sankyo Inc. | 10 | $211 |
| Merck | 11 | $201 |
| EMD Serono, Inc. | 7 | $176 |
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| Eisai Inc. | 12 | $166 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $137 |
| Bristol Myers Squibb | 6 | $132 |
| Pfizer | 13 | $129 |
| AstraZeneca | 6 | $127 |
| Novocure Inc. | 1 | $125 |
| Seagen Inc. | 2 | $117 |
| AbbVie | 5 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $96 |
| Johnson & Johnson | 4 | $90 |
| Incyte Corporation | 5 | $85 |
| Gilead | 4 | $82 |
| GSK | 3 | $58 |
| Tersera Therapeutics LLC | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Pharmaessentia USA Corporation | 2 | $44 |
| Sanofi | 2 | $43 |
| Beigene USA, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
| Recordati_rare_diseases_inc. | 2 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $29 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Tempus AI, Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| ADC Therapeutics America, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Mirati Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,164 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 46 | $1,044 |
| Hydroxyurea | 11 | $647 |
| Ondansetron OdtOndansetron | 16 | $488 |
| Acyclovir | 25 | $444 |
| Dexamethasone | 18 | $265 |
| Prochlorperazine Maleate | 22 | $257 |
| Levothyroxine Sodium | 16 | $184 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Orem
- Hayley LundeenOrem$9K
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.